Evidence map›Paper›PMID 28804679›Full record

ArticleMedical student research journal2017

Time to Neurological Deterioration in Ischemic Stroke.

James E Siegler, Karen C Albright, Alexander J George, Amelia K Boehme, Michael A Gillette, Andre D Kumar, Monica Aswani, Sheryl Martin-Schild

Abstract read
In one paragraph

Article in Medical student research journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

James E SieglerStroke Program, Department of Neurology, Tulane University Hospital, New Orleans, LA 70112.
Karen C AlbrightDepartment of Epidemiology, School of Public Health, University of Alabama at Birmingham, 35294.
Alexander J GeorgeStroke Program, Department of Neurology, Tulane University Hospital, New Orleans, LA 70112.
Amelia K BoehmeDepartment of Epidemiology, School of Public Health, University of Alabama at Birmingham, 35294.
Michael A GilletteStroke Program, Department of Neurology, Tulane University Hospital, New Orleans, LA 70112.
Andre D KumarStroke Program, Department of Neurology, Tulane University Hospital, New Orleans, LA 70112.
Monica AswaniDepartment of Department of Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham, Birmingham, AL 35249.
Sheryl Martin-SchildStroke Program, Department of Neurology, Tulane University Hospital, New Orleans, LA 70112.

Funding

UAB Health Services Research (HSR) Training ProgramT32HS013852 · AHRQ · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEVITAN, EMILY B, MUGAVERO, MICHAEL J · 2003 to 2024
$8.0M
AHRQ HHS T32 HS013852
6 · The paper itself

Abstract

backgroundNeurological deterioration (ND) is common, with nearly one-half of ND patients deteriorating within the first 24 to 48 hours of stroke. The timing of ND with respect to ND etiology and reversibility has not been investigated.

methodsAt our center, we define ND as an increase of 2 or more points in the National Institutes of Health Stroke Scale (NIHSS) score within 24 hours and categorize etiologies of ND according to clinical reversibility. ND etiologies were considered non-reversible if such causes may have produced or extended any areas of ischemic neurologic injury due to temporary or permanent impairment in cerebral perfusion.

resultsSeventy-one of 350 ischemic stroke patients experienced ND. Over half (54.9%) of the patients who experienced ND did so within the 48 hours of last seen normal. The median time to ND for non-reversible causes was 1.5 days (IQR 0.9, 2.4 days) versus 2.6 days for reversible causes (IQR 1.4, 5.5 days, p=0.011). After adjusting for NIHSS and hematocrit on admission, the log-normal survival model demonstrated that for each 1-year increase in a patient's age, we expect a 3.9% shorter time to ND (p=0.0257). In addition, adjusting for age and hematocrit on admission, we found that that for each 1-point increase in the admission NIHSS, we expect a 3.1% shorter time to ND (p=0.0034).

conclusionsWe found that despite having similar stroke severity and age, patients with nonreversible causes of ND had significantly shorter median time to ND when compared to patients with reversible causes of ND.

Indexed as

Acute ischemic strokelatencyneurological deteriorationtime to event analysis

Identifiers

PMID28804679
PMCPMC5553982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.